Repligen Corporation

RGEN · NASDAQ · Healthcare / Medical Instruments & Supplies

167.79USD+1.27 (+0.76%)

Price History

Full chart

Market Stats

Previous Close166.52

Open168.09

Day Range165.26 – 169.04

52-Week Range100.99 – 198.87

Volume510.10K

Market Cap10.95B

P/E (TTM)262.28

Forward P/E67.11

EPS0.74

Dividend Yield0.00%

Beta1.05

50-Day Avg165.95

200-Day Avg143.00

About

Repligen Corporation, a life sciences company, develops and commercializes bioprocessing technologies and systems in North America, Europe, the Asia Pacific, and internationally. The company's products include hollow fiber consumables, KRM chromatography system, resins for new modalities, PATsmart MAVERICK and PATsmart MAVEN for real-time monitoring and control of critical bioprocess parameters, PATsmart REBEL, an at-line cell culture media analyzer; and PATsmart ZipChip, a high-resolution sample separations device, PATsmart SoloVPE slope spectroscopy system, and SoloVPE PLUS System. It offers Protien A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products. The company also provides chromatography products, including OPUS pre-packed chromatography columns, which are used in the purification and quality control of biological drugs, as well as ELISA test kits. In addition, it offers filtration products, such as XCell ATF Cell Retention Systems that are filtration devices used in upstream perfusion and cell culture processing; TangenX flat sheet cassettes, which are used in downstream biologic drug concentration, buffer exchange, and formulation processes; KrosFlo tangential flow filtration and tangential flow depth filtration systems; and ProConnex TFDF flow paths. Further, it provides process analytics products, such as slope spectroscopy systems. The company offers its products under the OPUS, XCell, XCell ATF, TFDF, KrosFlo, SIUS, ProConnex, Spectra/Por, NGL-Impact, SoloVPE, FlowVPE, RPM, XO, Metenova MixOne, and AVIPure and FlowVPX brands. The company sells its products to life sciences, biopharmaceutical, and diagnostics companies; laboratory researchers; and contract manufacturing organizations. Repligen Corporation has a collaboration agreement with Navigo Proteins GmbH to develop multiple affinity ligands. The company was incorporated in 1981 and is headquartered in Waltham, Massachusetts.

Company Details

SectorHealthcare
IndustryMedical Instruments & Supplies
CEOMr. Olivier Loeillot
Employees2.00K
HeadquartersBuilding 1, Waltham, MA, United States, 02453, USA
Websitehttps://www.repligen.com

Leadership

Mr. Olivier LoeillotPresident, CEO & Director · b. 1970
Mr. Jason K. GarlandCFO & Chief Compliance Officer · b. 1974
Mr. James R. BylundChief Operating Officer · b. 1963
Mr. Anthony J. HuntAdvisor · b. 1964
Mr. Ralf KuriyelSenior Vice President of Research & Development · b. 1958
Mr. Brian DouglassSenior VP & Chief Product Officer · b. 1975
Ms. Violetta HughesChief Accounting Officer · b. 1973
Ms. Heather EmsChief Information Officer
Mr. Jacob K. Johnson C.F.A.Vice President of Investor Relations
Mr. George A Scott Jr., J.D., M.B.A.Senior VP & General Counsel

Financials

Income Statement

Currency: USD	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Revenue	3.70M	10.20M	8.50M	12.70M	7.60M	11.70M	27.30M	26.80M	16.90M	10.90M	3.80M	2.40M	2.60M	3.45M	2.35M	4.30M	7.77M	6.91M	9.36M	12.91M	14.07M	19.30M	29.36M	20.97M	27.29M	23.45B	62.27M	68.17M	63.55M	83.54M	104.54M	141.24M	194.03M	270.25M	366.26M	670.53M	801.54M	638.76M	634.44M	738.26M
Growth (%)	-	+175.68%	-16.67%	+49.41%	-40.16%	+53.95%	+133.33%	-1.83%	-36.94%	-35.50%	-65.14%	-36.84%	+8.33%	+32.72%	-31.99%	+83.30%	+80.67%	-11.03%	+35.38%	+37.94%	+9.01%	+37.10%	+52.16%	-28.58%	+30.14%	+85826.59%	-99.73%	+9.48%	-6.78%	+31.45%	+25.14%	+35.10%	+37.38%	+39.28%	+35.53%	+83.08%	+19.54%	-20.31%	-0.68%	+16.36%
Cost of Revenue	4.40M	7.20M	7.60M	10.50M	-600.00K	-200.00K	-500.00K	1.50M	-1.10M	100.00K	300.00K	300.00K	400.00K	782.23K	1.12M	1.99M	3.48M	3.25M	3.89M	3.55M	3.61M	6.16M	6.78M	5.51M	7.12M	6.47B	27.17M	25.16M	28.02M	35.25M	47.12M	67.05M	85.95M	132.02M	171.91M	279.28M	345.83M	354.52M	359.79M	390.63M
Gross Profit	-700.00K	3.00M	900.00K	2.20M	8.20M	11.90M	27.80M	25.30M	18.00M	10.80M	3.50M	2.10M	2.20M	2.67M	1.22M	2.31M	4.29M	3.67M	5.47M	9.36M	10.46M	13.14M	22.58M	15.46M	20.17M	16.98B	35.10M	43.01M	35.53M	48.29M	57.42M	74.19M	108.08M	138.22M	194.35M	391.25M	455.71M	284.25M	274.64M	347.62M
Gross Margin	-18.92%	29.41%	10.59%	17.32%	107.89%	101.71%	101.83%	94.40%	106.51%	99.08%	92.11%	87.50%	84.62%	77.33%	52.15%	53.67%	55.22%	53.02%	58.47%	72.50%	74.32%	68.08%	76.92%	73.74%	73.92%	72.40%	56.36%	63.09%	55.90%	57.80%	54.93%	52.53%	55.70%	51.15%	53.06%	58.35%	56.85%	44.50%	43.29%	47.09%
Operating Expense	4.20M	4.10M	4.30M	4.70M	16.50M	24.70M	39.10M	44.50M	38.30M	18.60M	4.00M	2.90M	3.70M	6.56M	8.56M	7.89M	9.39M	13.61M	9.63M	10.58M	12.28M	-22.76M	18.70M	21.23M	20.55M	18.08B	24.01M	20.13M	24.84M	34.52M	41.45M	60.18M	82.09M	98.14M	113.07M	224.00M	231.04M	229.67M	309.76M	288.05M
Operating Income	-4.90M	-1.10M	-3.40M	-2.50M	-8.30M	-12.80M	-11.30M	-19.20M	-20.30M	-7.80M	-500.00K	-800.00K	-1.50M	-3.89M	-7.33M	-5.58M	-5.09M	-9.94M	-4.16M	-1.22M	-1.83M	35.89M	3.88M	-5.77M	-374.07K	-1.11B	11.08M	22.87M	10.69M	13.76M	15.97M	14.01M	25.99M	40.08M	81.29M	167.25M	224.67M	54.58M	-35.11M	59.58M
Operating Margin	-132.43%	-10.78%	-40.00%	-19.69%	-109.21%	-109.40%	-41.39%	-71.64%	-120.12%	-71.56%	-13.16%	-33.33%	-57.69%	-112.74%	-312.46%	-129.67%	-65.55%	-143.77%	-44.46%	-9.45%	-12.97%	186.00%	13.21%	-27.50%	-1.37%	-4.72%	17.80%	33.55%	16.82%	16.48%	15.28%	9.92%	13.39%	14.83%	22.19%	24.94%	28.03%	8.54%	-5.53%	8.07%
EBITDA	-600.00K	-2.80M	-1.70M	-7.40M	-11.70M	-9.60M	-16.80M	-17.70M	-29.40M	-2.80M	-615.02K	-2.46M	-4.04M	-7.06M	-5.32M	-4.29M	-8.66M	-2.23M	-1.22M	-1.82M	36.72M	6.85M	-3.52M	1.66M	-30.47K	-322.28M	14.84M	26.13M	15.16M	22.44M	24.55M	24.14M	41.77M	56.31M	98.42M	203.27M	277.31M	124.29M	80.26M	164.30M
EBITDA Margin	-16.22%	-27.45%	-20.00%	-58.27%	-153.95%	-82.05%	-61.54%	-66.04%	-173.96%	-25.69%	-16.18%	-102.34%	-155.33%	-204.48%	-226.71%	-99.78%	-111.48%	-32.21%	-13.03%	-14.13%	260.88%	35.51%	-11.98%	7.90%	-0.11%	-1.37%	23.83%	38.33%	23.85%	26.86%	23.48%	17.09%	21.53%	20.84%	26.87%	30.31%	34.60%	19.46%	12.65%	22.26%
Net Income	-20.70M	300.00K	-3.30M	-2.40M	-5.70M	-12.80M	-11.30M	-19.50M	-32.00M	-11.50M	-500.00K	-800.00K	-2.50M	-3.82M	-5.28M	-4.46M	-4.54M	-9.55M	-2.98M	696.86K	-889.26K	37.11M	5.75M	-4.06M	-43.51K	-1.61B	14.16M	16.09M	8.17M	9.35M	11.68M	28.35M	16.62M	21.41M	59.93M	128.29M	185.96M	41.58M	-25.51M	48.89M
Net Income Margin	-559.46%	2.94%	-38.82%	-18.90%	-75.00%	-109.40%	-41.39%	-72.76%	-189.35%	-105.50%	-13.16%	-33.33%	-96.15%	-110.60%	-224.95%	-103.70%	-58.38%	-138.13%	-31.87%	5.40%	-6.32%	192.30%	19.57%	-19.38%	-0.16%	-6.88%	22.73%	23.61%	12.86%	11.19%	11.17%	20.07%	8.56%	7.92%	16.36%	19.13%	23.20%	6.51%	-4.02%	6.62%
R&D	-	-	-	-	-	-	-	-	31.00M	12.30M	1.40M	1.40M	1.80M	3.75M	5.79M	5.36M	5.23M	6.48M	5.04M	5.16M	5.92M	7.24M	12.77M	14.16M	12.53M	9.46B	10.49M	7.34M	5.61M	5.74M	7.36M	8.67M	15.77M	19.45M	19.66M	34.27M	43.94M	42.72M	43.20M	54.18M
R&D as % of Total Revenue	-	-	-	-	-	-	-	-	183.43%	112.84%	36.84%	58.33%	69.23%	108.79%	246.58%	124.62%	67.25%	93.78%	53.81%	39.99%	42.09%	37.52%	43.50%	67.52%	45.91%	40.35%	16.85%	10.77%	8.83%	6.87%	7.04%	6.14%	8.13%	7.20%	5.37%	5.11%	5.48%	6.69%	6.81%	7.34%
Interest Expense	20.70M	300.00K	3.30M	2.40M	5.70M	12.80M	11.30M	19.50M	0	32.00M	500.00K	800.00K	2.50M	3.82M	5.28M	4.46M	4.54M	9.55M	2.98M	696.86K	889.26K	2.96K	2.96K	1.97K	26.17K	0	56.71K	49.85K	49.96K	32.00K	3.77M	6.44M	6.71M	9.29M	12.13M	12.71M	2.98M	10.03M	22.57M	23.17M
Interest Expense % of Total Revenue	559.46%	2.94%	38.82%	18.90%	75.00%	109.40%	41.39%	72.76%	0.00%	293.58%	13.16%	33.33%	96.15%	110.60%	224.95%	103.70%	58.38%	138.13%	31.87%	5.40%	6.32%	0.02%	0.01%	0.01%	0.10%	0.00%	0.09%	0.07%	0.08%	0.04%	3.60%	4.56%	3.46%	3.44%	3.31%	1.90%	0.37%	1.57%	3.56%	3.14%

Balance Sheet

Currency: USD	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1986-12-31	1987-12-31	1988-12-31	1989-12-31	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Total Assets	23.00M	27.50M	24.70M	37.80M	54.20M	59.00M	47.40M	41.10M	31.30M	5.70M	6.70M	5.70M	5.20M	36.29M	32.15M	29.11M	33.15M	29.61M	27.61M	28.60M	29.08M	68.84M	73.75M	71.42M	72.29M	76.10M	97.01M	118.64M	-65.43M	146.24M	288.91M	120.41M	139.45M	1.40B	1.90B	2.36B	2.53B	2.82B	2.83B	2.95B
Total Liabilities	2.50M	2.80M	3.40M	2.60M	2.80M	7.40M	12.20M	12.70M	15.70M	800.00K	300.00K	400.00K	1.20M	1.26M	2.67M	2.24M	2.81M	3.32M	3.17M	3.54M	4.73M	4.63M	5.30M	5.21M	5.21M	10.10M	12.89M	14.76M	16.56M	23.49M	120.15M	151.92M	159.05M	340.35M	373.74M	608.29M	620.90M	853.21M	856.95M	843.57M
Total Equity	25.00M	21.90M	28.00M	35.20M	51.40M	51.60M	35.20M	28.40M	15.60M	4.90M	6.40M	5.30M	35.09M	30.89M	26.44M	24.55M	30.34M	24.29M	25.43M	25.54M	64.11M	69.12M	66.12M	67.09M	67.09M	66.00M	84.12M	103.89M	111.73M	122.75M	168.76M	-31.51M	615.57M	1.06B	1.53B	1.75B	1.91B	1.97B	1.97B	2.11B
Cash	18.00M	8.40M	8.60M	21.30M	40.30M	29.40M	15.10M	18.00M	13.80M	3.30M	4.90M	3.70M	3.30M	25.23M	16.16M	8.70M	2.37M	3.96M	3.22M	5.43M	7.73M	32.56M	5.04M	12.53M	14.20M	11.20M	29.21M	39.83M	62.00M	73.41M	141.78M	173.76M	193.82M	528.39M	717.29M	603.81M	523.46M	751.32M	757.36M	566.02M
Total Debt	100.00K	100.00K	100.00K	-	2.70M	4.60M	4.80M	4.60M	4.60M	4.60M	-	-	-	-	-	-	85.64K	119.89K	119.89K	-	-	-	-	-	-	-	-	-	-	-	95.27M	99.25M	103.49M	263.32M	275.42M	366.05M	422.96M	711.80M	686.25M	689.95M
Net Debt	-17.80M	-8.30M	-8.50M	-21.30M	-40.30M	-29.40M	-10.30M	-13.40M	-9.20M	-3.30M	-4.90M	-3.70M	-3.30M	-25.23M	-16.16M	-8.70M	-2.37M	-3.96M	-3.10M	-5.43M	-7.73M	-32.56M	-5.04M	-12.53M	-14.20M	-11.20M	-29.21M	-39.83M	-62.00M	-73.41M	-46.51M	-74.51M	-90.33M	-265.07M	-441.88M	-237.76M	-100.50M	-39.52M	-71.11M	123.93M

Cash Flow

Currency: USD	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31

Currency: USD	1990-12-31	1991-12-31	1992-12-31	1993-12-31	1994-12-31	1995-12-31	1996-12-31	1997-12-31	1998-12-31	1999-12-31	2000-12-31	2001-12-31	2002-12-31	2003-12-31	2004-12-31	2005-12-31	2006-12-31	2007-12-31	2008-12-31	2009-12-31	2010-12-31	2011-12-31	2012-12-31	2013-12-31	2014-12-31	2015-12-31	2016-12-31	2017-12-31	2018-12-31	2019-12-31	2020-12-31	2021-12-31	2022-12-31	2023-12-31	2024-12-31	2025-12-31
Operating Cash Flow	-5.70M	-8.60M	-1.90M	-24.80M	-14.60M	-9.30M	-3.20M	-700.00K	-1.20M	-3.13M	-4.62M	-4.75M	-5.26M	-5.72M	-795.28K	415.38K	405.48K	38.47M	6.31M	-2.45M	3.23M	2.31M	13.44M	25.93M	18.40M	15.05M	7.52M	17.45M	32.77M	67.22M	62.63M	119.02M	172.08M	113.92M	175.39M	117.42M
Investing Cash Flow	1.30M	-7.20M	-20.80M	4.00M	-	6.60M	-200.00K	-	-300.00K	-9.02M	-5.12M	-2.73M	2.67M	-8.41M	27.58K	1.46M	1.77M	-14.23M	-32.23M	9.92M	-1.50M	-5.01M	2.84M	-17.91M	-19.79M	4.79M	-49.19M	-98.25M	-14.04M	-205.31M	-201.38M	-221.17M	-233.24M	-	-86.38M	-298.47M
Financing Cash Flow	11.40M	24.60M	21.90M	17.90M	800.00K	-4.20M	-	2.00M	-	34.13M	677.14K	14.11K	-	11.98M	25.70K	332.50K	117.97K	597.69K	-1.60M	11.59K	-50.28K	-330.00K	1.16M	2.52M	1.68M	767.00K	112.11M	129.94M	3.41M	484.87M	305.92M	961.00K	-13.34M	248.96M	-82.90M	-15.21M
Capital Expenditure	1.10M	1.30M	18.20M	0	600.00K	500.00K	400.00K	100.00K	300.00K	217.26K	184.72K	307.97K	1.08M	307.77K	52.66K	735.50K	1.33M	1.10M	1.34M	597.35K	524.67K	575.46M	1.26M	4.63M	5.60M	2.63M	4.33M	5.45M	14.04M	23.15M	26.34M	67.09M	133.35M	38.99M	32.91M	23.52M
Free Cash Flow	-6.80M	-9.90M	-20.10M	-24.80M	-15.20M	-9.80M	-3.60M	-800.00K	-1.50M	-3.35M	-4.81M	-5.06M	-6.34M	-6.03M	-847.93K	-320.11K	-921.05K	37.36M	4.97M	-3.05M	2.71M	1.73M	12.18M	21.30M	12.80M	12.43M	3.20M	12.00M	18.73M	44.06M	36.28M	51.93M	38.74M	74.93M	142.49M	93.90M
Dividends Paid	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0	0	0	0	0	0	0	-	490.00K	-	2.90M	17.02M	565.68M	-	-
FCF to OCF	119.30%	115.12%	1057.89%	100.00%	104.11%	105.38%	112.50%	114.29%	125.00%	106.93%	104.00%	106.48%	120.61%	105.38%	106.62%	-77.06%	-227.15%	97.13%	78.75%	124.40%	83.77%	74.89%	90.60%	82.13%	69.55%	82.54%	42.49%	68.75%	57.17%	65.55%	57.93%	43.63%	22.51%	65.78%	81.24%	79.97%
Dividend Paid to FCF	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	-	1.11%	-	5.58%	43.93%	754.95%	-	-

Earnings

Report Date	Feb 12, 1993	May 19, 1993	Jul 30, 1993	Nov 9, 1993	Feb 14, 1994	Jun 2, 1994	Jul 19, 1994	Nov 1, 1994	Feb 14, 1995	Aug 16, 1995	Jun 30, 1998	Sep 30, 1998	Dec 31, 1998	Mar 31, 1999	Jun 30, 1999	Sep 30, 1999	Dec 31, 1999	Mar 31, 2000	Jun 30, 2000	Sep 30, 2000	Dec 31, 2000	Mar 31, 2001	Jun 30, 2001	Sep 30, 2001	Dec 31, 2001	Mar 31, 2002	Jun 30, 2002	Sep 30, 2002	Feb 6, 2003	Jun 5, 2003	Jul 31, 2003	Nov 12, 2003	Feb 11, 2004	Jun 10, 2004	Aug 9, 2004	Nov 9, 2004	Feb 4, 2005	May 25, 2005	Jul 27, 2005	Nov 3, 2005	Feb 9, 2006	Jun 8, 2006	Aug 8, 2006	Nov 2, 2006	Feb 8, 2007	Jun 7, 2007	Aug 8, 2007	Nov 8, 2007	Feb 7, 2008	Jun 12, 2008	Aug 7, 2008	Nov 6, 2008	Feb 5, 2009	Jun 11, 2009	Aug 6, 2009	Nov 5, 2009	Feb 4, 2010	Jun 9, 2010	Aug 5, 2010	Nov 2, 2010	Feb 9, 2011	Jun 9, 2011	Jul 27, 2011	Oct 27, 2011	May 3, 2012	Aug 2, 2012	Nov 8, 2012	Mar 7, 2013	May 2, 2013	Aug 1, 2013	Nov 7, 2013	Mar 6, 2014	May 8, 2014	Aug 11, 2014	Nov 6, 2014	Mar 13, 2015	May 7, 2015	Aug 6, 2015	Nov 5, 2015	Feb 25, 2016	May 5, 2016	Aug 4, 2016	Nov 3, 2016	Feb 22, 2017	May 4, 2017	Aug 3, 2017	Nov 9, 2017	Feb 22, 2018	May 8, 2018	Aug 2, 2018	Nov 1, 2018	Feb 21, 2019	May 9, 2019	Aug 1, 2019	Oct 31, 2019	Feb 20, 2020	May 6, 2020	Jul 30, 2020	Nov 5, 2020	Feb 24, 2021	May 4, 2021	Jul 27, 2021	Oct 28, 2021	Feb 17, 2022	Apr 27, 2022	Aug 2, 2022	Nov 1, 2022	Feb 22, 2023	May 2, 2023	Aug 2, 2023	Oct 31, 2023	Feb 21, 2024	May 1, 2024	Jul 30, 2024	Nov 12, 2024	Feb 19, 2025	Apr 29, 2025	Jul 29, 2025	Oct 28, 2025	Feb 25, 2026	May 5, 2026	Jul 28, 2026	Oct 27, 2026
EPS Estimate	-0.36	-0.36	-0.39	-0.38	-0.37	-0.31	-0.40	-0.39	-0.39	-0.31	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-0.04	-0.06	-0.04	-0.08	-0.05	-0.04	-0.06	-0.04	-0.04	-0.10	-0.02	-0.02	-0.01	-0.02	-0.02	-0.02	-0.02	-0.01	-0.01	-0.05	-0.02	0.16	-0.04	-0.03	-0.06	-0.04	-0.04	-0.07	-0.04	-	-0.04	-0.03	-0.03	-0.01	-0.02	-	0.01	0.02	-	0.11	0.10	0.04	0.14	0.09	0.06	0.04	0.04	0.07	0.09	0.07	0.07	0.13	0.13	0.08	0.07	0.13	0.15	0.11	0.12	0.15	0.18	0.18	0.21	0.22	0.30	0.19	0.18	0.21	0.28	0.28	0.31	0.42	0.52	0.64	0.65	0.72	0.71	0.68	0.58	0.59	0.48	0.16	0.33	0.30	0.33	0.33	0.42	0.35	0.39	0.41	0.44	0.39	0.45	0.46
EPS Actual	-0.34	-0.27	-0.37	-0.38	-0.45	-0.34	-0.39	-0.45	-0.38	-0.17	-0.02	-0.01	-0.02	-0.09	-0.02	-0.04	-0.08	-0.03	-0.04	-0.05	-0.06	-0.06	-0.05	-0.05	-0.03	-0.03	-0.04	-0.04	-0.03	-0.06	-0.07	-0.07	-0.07	-0.03	-0.02	-0.06	-0.01	-0.01	0.03	-0.02	-0.01	-0.03	0.00	-0.03	-0.00	-0.00	0.01	1.31	-0.01	-0.10	0.26	0.00	0.00	-0.09	-0.04	-0.03	-0.01	-0.05	0.03	0.02	0.01	-0.06	0.01	0.02	0.04	0.05	0.07	0.30	0.07	0.14	0.05	0.10	0.13	0.09	0.04	0.02	0.09	0.11	0.08	0.01	0.12	0.16	0.08	0.08	0.15	0.20	0.15	0.20	0.17	0.16	0.20	0.21	0.28	0.31	0.26	0.20	0.32	0.42	0.40	0.52	0.68	0.79	0.78	0.81	0.92	0.91	0.77	0.68	0.64	0.53	0.23	0.33	0.28	0.33	-0.01	0.44	0.39	0.37	0.46	0.49	0.48	0.54	-
Surprise	5.56%	25.00%	5.13%	0.00%	-21.62%	-9.68%	2.50%	-15.38%	2.56%	45.16%	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-50.00%	-16.67%	-75.00%	12.50%	40.00%	50.00%	0.00%	75.00%	75.00%	130.00%	0.00%	50.00%	-200.00%	116.50%	-50.00%	97.00%	82.50%	200.00%	13200.00%	80.00%	-400.00%	62.50%	111.25%	102.00%	-50.00%	0.00%	25.00%	85.71%	-25.00%	-	150.00%	133.33%	-100.00%	200.00%	200.00%	-	400.00%	250.00%	-	-36.36%	40.00%	25.00%	-28.57%	44.44%	50.00%	0.00%	-50.00%	28.57%	22.22%	14.29%	-85.71%	-7.69%	23.08%	0.00%	14.29%	15.38%	33.33%	36.36%	66.67%	13.33%	-11.11%	11.11%	0.00%	27.27%	3.33%	36.84%	11.11%	52.38%	50.00%	42.86%	67.74%	61.90%	51.92%	21.88%	24.62%	27.78%	28.17%	13.24%	17.24%	8.47%	10.42%	43.75%	0.00%	-6.67%	0.00%	-103.55%	4.99%	11.43%	-5.13%	12.20%	11.52%	23.08%	20.00%	-
Timing	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	-	After-hours	Pre-market	After-hours	-	After-hours	After-hours	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	-	Pre-market	-	-	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	Pre-market	-	Pre-market	Pre-market	-

Key Statistics & Ratios

Market Cap10.95B

Enterprise Value10.29B

Trailing P/E262.28

Forward P/E67.11

PEG Ratio1.84

Price / Sales13.95

Price / Book4.93

EPS0.74

Book Value37.43

Revenue (TTM)785.10M

Gross Profit (TTM)422.67M

EBITDA144.10M

Profit Margin5.29%

Operating Margin9.31%

Return on Equity1.99%

Return on Assets1.40%

Shares Outstanding56.44M

Shares Float53.47M

Beta1.05

Dividend Yield0.00%

Dividend Rate0.00

Payout Ratio0.00%

Analyst Ratings

Buy

Based on 19 analystsTarget 189.48

Strong Buy
10
Buy
4
Hold
5

Ownership Breakdown

Institutions: 120.04%
Insiders: 5.25%
Retail / Other: 0.00%

Top Institutional Holders

BlackRock Inc
5.99M10.62%
T. Rowe Price Associates, Inc.
4.88M8.64%
FMR Inc
2.89M5.12%
United Capital Financial Advisers Inc
2.77M4.92%
Vanguard Capital Management, LLC
2.40M4.25%
Vanguard Portfolio Management, LLC
2.31M4.08%
State Street Corp
1.78M3.15%
Wasatch Advisors LP
1.59M2.82%
Bank of New York Mellon Corp
1.53M2.71%
Maverick Capital Ltd
1.52M2.69%
Massachusetts Financial Services Company
1.40M2.48%
T. Rowe Price Investment Management,Inc.
1.37M2.42%
Amvescap Plc.
1.28M2.27%
RTW INVESTMENTS, LLC
1.21M2.14%
Franklin Templeton Inc
1.19M2.11%
Geode Capital Management, LLC
1.06M1.89%
Congress Asset Management Company, LLP
1.01M1.79%

Top Fund Holders

iShares Core S&P Mid-Cap ETF
1.86M3.29%
Vanguard MStar Total Stk Mkt Idx Invest
1.70M3.02%
Vanguard Small Cap Index
1.23M2.18%